Ernexa Financials
This page shows Ernexa (ERNA) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Ernexa's business model still runs on external financing while lower cash burn buys time rather than self-funded operations.
Operating cash burn dropped from$20.4M to$7.0M , and free cash burn stayed almost identical to operating burn, showing the improvement came from lower operating spending rather than reduced reinvestment. FY2025 cash of$1.9M still sat below the year's$7.0M burn, so operations remain funded by fresh capital instead of internal cash generation.
This is still a pre-commercial cost structure: FY2025 R&D plus SG&A totaled
Financing, not operations, supplied the cash: FY2025 financing inflow of
Financial Health Signals
Ernexa does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
Ernexa passes 3 of 5 computable financial strength tests (4 of the nine could not be computed from available data). 1 of 3 profitability signals pass, all 2 leverage/liquidity signals pass.
Ernexa reported a net loss of $14.1M while operations used $7.0M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Ernexa reported an operating loss of $9.3M against $22K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Ernexa's EBITDA was -$9.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 40.4% from the prior year.
Ernexa reported -$14.1M in net income in fiscal year 2025.
Not reported for fiscal year 2025.
Cash & Balance Sheet
Ernexa recorded an outflow of $7.1M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents an increase of 56.5% from the prior year.
Ernexa held $1.9M in cash as of fiscal year 2025; long-term debt is not reported for that period.
Not reported for fiscal year 2025.
Margins & Returns
Ernexa's ROE was -586.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Capital Allocation
Ernexa invested $4.2M in research and development in fiscal year 2025. This represents a decrease of 9.7% from the prior year.
Ernexa invested $37K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 90.0% from the prior year.
Not reported for fiscal year 2025.
ERNA Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | $582K+755.9% | $68K | $0 | N/A | $5.8M-70.7% | $19.8M-15.1% | $23.3M+9.7% | $21.3M-4.7% | $22.3M-9.0% | $24.5M-5.9% | $26.0M+9.7% | $23.7M-1.3% | $24.1M+0.8% | $23.9M |
| Cost of Revenue | N/A | N/A | $96K-59.3% | $236K | $0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | $486K+389.3% | -$168K | $0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | $4.2M-9.7% | $4.6M-22.2% | $5.9M-43.0% | $10.4M-18.2% | $12.7M+635150.0% | $2K-92.3% | $26K-63.9% | $72K-48.2% | $139K | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | N/A | $5.2M-60.7% | $13.1M-10.0% | $14.6M-13.4% | $16.8M+14.3% | $14.7M+82.0% | $8.1M-38.6% | $13.2M-8.9% | $14.5M-7.2% | $15.6M-5.3% | $16.5M-8.9% | $18.1M-1.7% | $18.4M+13.2% | $16.2M-11.1% | $18.2M-10.8% | $20.4M |
| Operating Income | N/A | -$9.3M+40.5% | -$15.7M+25.8% | -$21.1M+36.4% | -$33.2M+70.8% | -$113.7M-1469.2% | -$7.2M-311.4% | -$1.8M-968.0% | $203K+114.5% | -$1.4M+38.5% | -$2.3M+67.0% | -$6.9M-45.4% | -$4.7M-323.8% | -$1.1M-5.4% | -$1.1M+67.6% | -$3.3M |
| Interest Expense | N/A | $22K-87.4% | $174K-71.7% | $614K+1946.7% | $30K | N/A | $118K-50.0% | $236K-20.3% | $296K-30.4% | $425K-17.8% | $517K+82.7% | $283K+26.9% | $223K+757.7% | $26K-40.9% | $44K-15.4% | $52K |
| Income Tax | N/A | -$45K-250.0% | $30K+1100.0% | -$3K-106.7% | $45K-29.7% | $64K | $0-100.0% | $27K+142.2% | -$64K-197.0% | $66K+73.7% | $38K+216.7% | $12K-85.7% | $84K+82.6% | $46K+155.4% | -$83K-150.9% | $163K |
| Net Income | N/A | -$14.1M | N/A | -$21.7M+11.8% | -$24.6M+79.9% | -$122.5M-1580.8% | -$7.3M-256.2% | -$2.0M-690.3% | -$259K+76.0% | -$1.1M+63.2% | -$2.9M+59.5% | -$7.2M-43.7% | -$5.0M-377.7% | -$1.1M-5.8% | -$995K+70.9% | -$3.4M |
| EPS (Diluted) | — | -$2.24 | -$48.96-1100.0% | -$4.08 | -$8.06 | -$56.61 | -$0.41 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
ERNA Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.8M+10.7% | $5.3M-89.3% | $49.1M+120.5% | $22.3M-29.3% | $31.5M+144.3% | $12.9M-8.6% | $14.1M-5.0% | $14.9M-10.3% | $16.6M-0.7% | $16.7M+1.7% | $16.4M-26.3% | $22.3M+44.1% | $15.5M+22.1% | $12.7M+8.7% | $11.6M |
| Current Assets | $3.1M+33.2% | $2.4M-75.5% | $9.6M-29.8% | $13.7M-27.1% | $18.8M+983.5% | $1.7M-71.5% | $6.1M-10.5% | $6.8M-29.6% | $9.6M-9.6% | $10.7M+17.0% | $9.1M-38.7% | $14.9M+87.8% | $7.9M+87.2% | $4.2M+51.1% | $2.8M |
| Cash & Equivalents | $1.9M+9.0% | $1.7M-77.2% | $7.6M-33.8% | $11.4M-32.6% | $17.0M+2086.0% | $777K-75.8% | $3.2M+26.5% | $2.5M-24.9% | $3.4M-40.6% | $5.7M+76.4% | $3.2M-55.1% | $7.2M+31.7% | $5.5M+100.5% | $2.7M+98.0% | $1.4M |
| Accounts Receivable | N/A | N/A | N/A | N/A | $684K | $0-100.0% | $1.2M+4.5% | $1.1M+60.1% | $714K-23.1% | $928K+1.0% | $919K-58.0% | $2.2M+241.7% | $641K+5.1% | $610K-18.7% | $750K |
| Goodwill | $2.0M0.0% | $2.0M0.0% | $2.0M0.0% | $2.0M0.0% | $2.0M0.0% | $2.0M+193.7% | $696K+4.3% | $667K-33.6% | $1.0M+7.2% | $937K+3.1% | $909K-16.1% | $1.1M-8.1% | $1.2M-6.8% | $1.3M+2.3% | $1.2M |
| Total Liabilities | $3.4M-3.8% | $3.6M-92.4% | $46.9M+361.1% | $10.2M+68.9% | $6.0M+14.8% | $5.2M+19.7% | $4.4M-44.9% | $7.9M-28.0% | $11.0M-12.6% | $12.6M+0.5% | $12.6M+10.7% | $11.3M+81.4% | $6.3M+31.4% | $4.8M-10.1% | $5.3M |
| Current Liabilities | $3.1M+6.0% | $2.9M-55.3% | $6.6M-14.1% | $7.7M+108.2% | $3.7M+17.7% | $3.1M | N/A | $4.0M-62.6% | $10.7M+61.8% | $6.6M+29.7% | $5.1M-27.8% | $7.1M+96.6% | $3.6M+6.5% | $3.4M-12.4% | $3.9M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | $532K | N/A | $3.8M-26.8% | $5.1M-36.8% | $8.1M+9.0% | $7.4M+39.8% | $5.3M+233.9% | $1.6M | N/A | N/A |
| Total Equity | $2.4M+41.2% | $1.7M-23.8% | $2.2M-81.6% | $12.1M-52.5% | $25.5M+233.0% | $7.7M-21.4% | $9.7M+40.9% | $6.9M+24.9% | $5.5M+36.1% | $4.1M+5.7% | $3.8M-64.8% | $10.9M+18.7% | $9.2M+16.6% | $7.9M+24.3% | $6.3M |
| Retained Earnings | -$245.6M-6.1% | -$231.5M-23.8% | -$187.0M-13.1% | -$165.3M-17.5% | -$140.7M-675.6% | -$18.1M+86.2% | -$131.5M-1.6% | -$129.4M-0.2% | -$129.1M-0.9% | -$128.0M-2.3% | -$125.1M-6.1% | -$117.8M-4.5% | -$112.8M-1.0% | -$111.7M-0.9% | -$110.7M |
Not reported in any period shown, so not listed: Inventory.
ERNA Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$8.8M | -$7.0M+55.7% | -$15.8M+22.4% | -$20.4M+2.7% | -$21.0M+10.7% | -$23.5M-189.9% | -$8.1M-395.2% | $2.7M+101.0% | $1.4M+148.6% | $549K+2287.0% | $23K+100.6% | -$4.2M+34.5% | -$6.4M-466.7% | $1.7M-19.2% | $2.2M+275.6% | $574K |
| Capital Expenditures | N/A | $37K-90.0% | $369K+1842.1% | $19K-93.6% | $297K+92.9% | $154K+294.9% | $39K-69.5% | $128K-80.2% | $648K-11.0% | $728K+70.5% | $427K-56.9% | $991K+18.7% | $835K-24.7% | $1.1M-9.5% | $1.2M-23.1% | $1.6M |
| Free Cash Flow | N/A | -$7.1M+56.5% | -$16.2M+20.7% | -$20.4M+4.0% | -$21.3M+10.0% | -$23.6M-190.4% | -$8.1M-411.2% | $2.6M+264.9% | $717K+500.6% | -$179K+55.7% | -$404K+92.2% | -$5.2M+28.4% | -$7.2M-1242.4% | $632K-32.0% | $930K+191.2% | -$1.0M |
| Investing Cash Flow | N/A | -$37K+89.9% | -$365K-1821.1% | -$19K+59.6% | -$47K+99.8% | -$22.7M-58212.8% | -$39K+96.3% | -$1.1M+32.6% | -$1.6M-8.7% | -$1.5M-72.9% | -$840K+48.2% | -$1.6M | N/A | N/A | -$2.8M+0.5% | -$2.8M |
| Financing Cash Flow | $9.6M | $7.2M+15.2% | $6.3M-62.2% | $16.6M-15.4% | $19.6M-68.2% | $61.6M+1219.0% | $4.7M+525.2% | -$1.1M-262.4% | -$303K+79.4% | -$1.5M-145.1% | $3.3M+64.4% | $2.0M | N/A | N/A | $2.0M+750.7% | -$300K |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
ERNA Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | 83.5% | -247.1% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | -2693.1% | -31080.9% | N/A | N/A | -125.0% | -8.9%-9.8pp | 0.9%+7.5pp | -6.6%+3.6pp | -10.2%+17.9pp | -28.1%-9.9pp | -18.2%-13.5pp | -4.7%-0.3pp | -4.4%+9.3pp | -13.7% |
| Net Margin | N/A | N/A | -31864.7% | N/A | N/A | -125.7% | -10.3%-9.2pp | -1.1%+4.0pp | -5.1%+8.0pp | -13.1%+16.4pp | -29.5%-10.2pp | -19.3%-14.9pp | -4.4%-0.3pp | -4.1%+10.2pp | -14.3% |
| Return on Equity | -586.6% | N/A | -970.4%-767.3pp | -203.0%+277.5pp | -480.5%-385.3pp | -95.2%-74.2pp | -21.0%-17.3pp | -3.7%+15.7pp | -19.4%+52.4pp | -71.9%+115.9pp | -187.8%-141.7pp | -46.1%-34.6pp | -11.4%+1.2pp | -12.6%+41.2pp | -53.8% |
| Return on Assets | -241.4% | N/A | -44.1%+66.2pp | -110.3%+278.4pp | -388.7%-332.2pp | -56.5%-42.0pp | -14.5%-12.8pp | -1.7%+4.8pp | -6.5%+11.0pp | -17.5%+26.5pp | -44.0%-21.5pp | -22.6%-15.8pp | -6.8%+1.1pp | -7.9%+21.5pp | -29.4% |
| Current Ratio | 1.01+0.2x | 0.80-0.7x | 1.46-0.3x | 1.79-3.3x | 5.10+4.5x | 0.55 | N/A | 1.69+0.8x | 0.90-0.7x | 1.60-0.2x | 1.78-0.3x | 2.10-0.1x | 2.19+0.9x | 1.25+0.5x | 0.72 |
| Debt-to-Equity | 1.43-0.7x | 2.10-18.9x | 21.00+20.2x | 0.84+0.6x | 0.24+0.2x | 0.07-0.4x | 0.45-0.1x | 0.54-0.4x | 0.93-1.1x | 1.99+0.1x | 1.93+1.4x | 0.49+0.3x | 0.17-0.4x | 0.60-0.2x | 0.83 |
| FCF Margin | N/A | -2784.4% | -30039.7% | N/A | N/A | -140.3% | 13.2%+10.1pp | 3.1%+3.9pp | -0.8%+1.0pp | -1.8%+19.3pp | -21.1%+6.6pp | -27.7%-30.4pp | 2.7%-1.2pp | 3.9%+8.1pp | -4.3% |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Gross Margin, Operating Margin, Net Margin, FCF Margin.
Similar Companies
Where Ernexa Ranks
Frequently Asked Questions
Is Ernexa profitable?
No, Ernexa (ERNA) reported a net income of -$14.1M in fiscal year 2025.
What is Ernexa's EBITDA?
Ernexa (ERNA) had EBITDA of -$9.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Ernexa's return on equity (ROE)?
Ernexa (ERNA) has a return on equity of -586.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Ernexa's free cash flow?
Ernexa (ERNA) recorded an outflow of $7.1M in free cash flow during fiscal year 2025. This represents a 56.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Ernexa's operating cash flow?
Ernexa (ERNA) recorded an outflow of $7.0M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Ernexa's total assets?
Ernexa (ERNA) had $5.8M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Ernexa's capital expenditures?
Ernexa (ERNA) invested $37K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Ernexa spend on research and development?
Ernexa (ERNA) invested $4.2M in research and development during fiscal year 2025.
What is Ernexa's current ratio?
Ernexa (ERNA) had a current ratio of 1.01 as of fiscal year 2025, which is considered adequate.
What is Ernexa's debt-to-equity ratio?
Ernexa (ERNA) had a debt-to-equity ratio of 1.43 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Ernexa's return on assets (ROA)?
Ernexa (ERNA) had a return on assets of -241.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Ernexa's cash runway?
Based on fiscal year 2025 data, Ernexa (ERNA) had $1.9M in cash against an annual operating cash burn of $7.0M. This gives an estimated cash runway of approximately 3 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Ernexa's Piotroski F-Score?
Ernexa (ERNA) has a Piotroski F-Score of 3 out of 5 computable signals; 4 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Ernexa's earnings high quality?
Ernexa (ERNA) reported a net loss of $14.1M while operations used $7.0M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Ernexa cover its interest payments?
Ernexa (ERNA) reported an operating loss of $9.3M against $22K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.